CMS finalized the GLOBE demonstration program aimed at matching Medicare drug prices to international rates, but projected savings fell dramatically from $11.9 billion to $440 million after exempting 96% of drugmakers. Only four companies will participate after others signed separate pricing agreements.
The Inflation Reduction Act's Medicare out-of-pocket cap is reducing costs for cancer patients, but community oncology leaders warn that negotiated drug price cuts are creating financial pressures on medical practices.
The Trump administration has proposed a new regulation through the Centers for Medicare & Medicaid Services targeting hospitals in the 340B Drug Pricing Program, aiming to prevent markups on discounted drugs for Medicare patients and potentially save consumers $1.1 billion next year.
The Department of Justice has announced the creation of a new West Coast Health Care Fraud Strike Force to investigate fraud targeting Medicare and other government health programs in western states including Nevada, responding to criminals following retiree migration patterns.
The Centers for Medicare & Medicaid Services and FDA announced a new pathway to streamline Medicare coverage for breakthrough medical devices, cutting red tape and providing predictability for device manufacturers and faster patient access to life-changing technologies.
Health Secretary RFK Jr. declared a public health emergency for Hawaii in response to severe weather events, providing federal healthcare providers and suppliers greater flexibility to meet emergency needs of Medicare and Medicaid beneficiaries in the affected areas.
A Harvard-backed study found that the Inflation Reduction Act's drug provisions are helping Medicare beneficiaries stay on their medications. However, the reforms have not yet reduced overall healthcare costs or financial anxiety for beneficiaries.
